Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Laura Sepp-Lorenzino Insider Profile
11 Followers
Laura Sepp-Lorenzino, EVP, Chief Scientific Officer at Intellia Therapeutics, holds 77.39K shares in Intellia Therapeutics (Ticker: NTLA), holds 49.22K shares in Taysha Gene Therapies (Ticker: TSHA). Most recently, Laura Sepp-Lorenzino Sold ― shares of Intellia Therapeutics on Jan 07, 2025 for an estimated value of 109.21K.
Laura Sepp-Lorenzino Intellia Therapeutics (NTLA)EVP, Chief Scientific Officer
Intellia Therapeutics (NTLA)
EVP, Chief Scientific Officer
Ranked #20,799 out of 100,285 Corporate Insiders
Profitable Transactions
3 out of 3 Profitable Transactions
Average Return
+33.50%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Laura Sepp-Lorenzino holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Jan 05, 2024 - Jan 05, 2025
Return:+57.60%
The most profitable trade made by Laura Sepp-Lorenzino
Laura Sepp-Lorenzino's Trading History
Intellia Therapeutics
Jan 07, 2025
EVP, Chief Scientific Officer
Informative Sell
109.21K
$735.19K
Taysha Gene Therapies
May 31, 2024
Director
Uninformative Buy
―
$75.31K
List of latest transactions for each holding click on a transaction to see Laura Sepp-Lorenzino's performance on stock
You May Also Like
Laura Sepp-Lorenzino insider profile FAQ
What is the percentage of profitable transactions made by Laura Sepp-Lorenzino?
The percentage of profitable transactions made by Laura Sepp-Lorenzino is 100%.
What is the average return per transaction made by Laura Sepp-Lorenzino?
The average return per transaction made by Laura Sepp-Lorenzino is 33.50%.
What stocks does Laura Sepp-Lorenzino hold?
Laura Sepp-Lorenzino holds: NTLA, TSHA stocks.
What was Laura Sepp-Lorenzino’s latest transaction?
Laura Sepp-Lorenzino latest transaction was an Informative Sell of $109.21K.
What was Laura Sepp-Lorenzino's most profitable transaction?
Laura Sepp-Lorenzino’s most profitable transaction was an Informative Sell of NTLA stock on January 5, 2024. The return on the trade was 57.60%.
What is Laura Sepp-Lorenzino's role in Intellia Therapeutics?
Laura Sepp-Lorenzino's role in Intellia Therapeutics is EVP, Chief Scientific Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.